Li Zheng

Dr. Li Zheng

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
XWXin Wang
Xin Wang
QLQianqian Liang
Qianqian Liang
LZLi Zheng
Li Zheng
FLFeng-sen Li
Feng-sen Li
The proportion of obese or overweight patients in COPD patients is increasing. Although BMI, WC and other easy to measure indicators have been proven to be related to the risk of COPD, they cannot accurately reflect the distribution and changes of body composition, ignoring the body composition (such as fat distribution, muscle content, water content, etc.), the relationship between it and disease risk may be missed. By analyzing the correlation between different body composition indexes and COPD patients, we can provide new research ideas for the prognosis judgment or intervention of COPD disease.

7 April 2025 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
QLQianqian Liang
Qianqian Liang
YWYide Wang
Yide Wang
LZLi Zheng
Li Zheng
Chronic Obstructive Pulmonary Disease (COPD) is a complex and diverse respiratory disorder, characterized by ongoing respiratory symptoms and restricted airflow. The major clinical manifestations typically encompass chronic cough, sputum production, and wheezing. The main pathological characteristics involve infiltration of inflammatory cells, overproduction of mucus, and damage to the alveolar walls. The underlying causes of COPD are complex and remain incompletely elucidated, thought to originate from the combined effect of various factors. Lipids, as hydrophobic molecules, fulfill three fundamental functions: energy storage, membrane biosynthesis, and signal transduction. Lipid metabolism is intricately intertwined with various metabolic pathways and plays a pivotal role in the complex pathogenesis of COPD. Delving into lipid metabolism, as well as the particular modifications and roles of lipid molecules in cells, is of paramount importance in the context of COPD. This review primarily aims to elucidate the role of fatty acid metabolism in the onset and progression of COPD. Additionally, it examines the potential of lipid metabolism reprogramming as a promising therapeutic approach, illuminating new paths for the management and treatment of this disabling respiratory condition.

8 January 2025 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
QLQianqian Liang
Qianqian Liang
YWYide Wang
Yide Wang
LZLi Zheng
Li Zheng
Background: Diabetes and chronic obstructive pulmonary disease (COPD) are prominent global health challenges, each imposing significant burdens on affected individuals, healthcare systems, and society. However, the specific molecular mechanisms supporting their interrelationship have not been fully defined.Methods: We identified the differentially expressed genes (DEGs) of COPD and diabetes from multi-center patient cohorts, respectively. Through cross-analysis, we identified the shared DEGs of COPD and diabetes, and investigated alterations of signaling pathways using Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and gene set enrichment analysis (GSEA). By using weighted gene correlation network analysis (WGCNA), key gene modules for COPD and diabetes were identified, and various machine learning algorithms were employed to identify shared biomarkers. Using xCell, we investigated the relationship between shared biomarkers and immune infiltration in diabetes and COPD. Single-cell sequencing, clinical samples, and animal models were used to confirm the robustness of shared biomarkers.Results: Cross-analysis identified 186 shared DEGs between diabetes and COPD patients. Functional enrichment results demonstrate that metabolic and immune-related pathways are common features altered in both diabetes and COPD patients. WGCNA identified 526 genes from key gene modules in COPD and diabetes. Multiple machine learning algorithms identified 4 shared biomarkers for COPD and diabetes, including CADPS, EDNRB, THBS4 and TMEM27. Finally, the 4 shared biomarkers were validated in single-cell sequencing data, clinical samples, and animal models, and their expression changes were consistent with the results of bioinformatic analysis.Conclusions: Through comprehensive bioinformatics analysis, we revealed the potential connection between diabetes and COPD, providing a theoretical basis for exploring the common regulatory genes.

16 May 2026 in Journal of Translational Medicine
Verified
Journal Article
Open access
YZYunfang Zhang
Yunfang Zhang
FLFengsen Li
Fengsen Li
LWLing Wang
Ling Wang
DXDan Xu
Dan Xu
JJJing Jing
Jing Jing
LZLi Zheng
Li Zheng
In recent years, the complexity of viral infections has escalated, leading to a steady rise in the number of patients suffering from viral pneumonia. Both innate and adaptive immune cells play a crucial role in the development and clinical presentation of this condition. Viruses not only initiate the antiviral immune response within the human body but also provoke uncontrolled inflammatory reactions. Severe viral infections are often marked by a “cytokine storm,” characterized by an excessive release of proinflammatory cytokines. This cytokine storm can lead to abnormalities in immune cells, particularly neutrophils and macrophages, as well as dysfunction in lymphocytes. Such disruptions caused by respiratory viruses may result in respiratory failure, significant multi-organ dysfunction, and sepsis. Therefore, understanding the pathogenic mechanisms through which respiratory viral infections impact immune cells is crucial for guiding clinical treatment and prognosis. Furthermore, effectively modulating immune cell responses in virus-infected hosts—by enhancing antiviral immunity and mitigating systemic inflammation—may be essential for treating viral pneumonia. This review highlights the roles of various immune cells in viral pneumonia and explores the mechanisms by which viral infections induce immune cell abnormalities, offering insights for future clinical strategies and improving prognosis for respiratory viral infections.

11 July 2025 in Open Medicine Journal
Verified
Journal Article
Open access
PDF file
WZWei Zhao
Wei Zhao
YWYide Wang
Yide Wang
DXDan Xu
Dan Xu
JJJing Jing
Jing Jing
JWJing Wang
Jing Wang
LZLi Zheng
Li Zheng
Introduction: Tuberculosis-associated obstructive pulmonary disease (TOPD) remains poorly understood; accumulating evidence implicates innate lymphoid cells (ILCs), especially group 3 (ILC3), in post-tuberculous airway remodelling. We aimed to clarify whether CXCL13-CXCR5–directed ILC3 chemotaxis contributes to secondary airflow limitation. Methods: In a case-control study, 34 patients with TOPD, 34 with stable chronic obstructive pulmonary disease (COPD) unrelated to tuberculosis, and 34 healthy controls were recruited. Peripheral blood and broncho-alveolar lavage fluid (BALF) were collected within 24 h of enrolment. Total ILCs and subsets were quantified using multiparameter flow cytometry; ELISA was used to measure CXCL13, CXCR5, IFN-γ, IL-23, IL-17, and IL-22. Group differences were analysed with one-way ANOVA or the Friedman test (p < 0.05). Results: Circulating ILC3 frequency was reduced in TOPD versus COPD and controls (p < 0.001). Conversely, the BALF ILC3 proportion was markedly higher in TOPD than in COPD and control subjects (p < 0.001). TOPD patients exhibited the greatest systemic elevation of CXCL13, IL-23, IL-17, and IL-22 (all p < 0.01) and the highest BALF levels of CXCL13, CXCR5, and the same cytokines (all p < 0.001). IFN-γ levels and BALF ILC1 counts were also elevated, whereas changes in ILC2 were restricted to peripheral blood. Discussion: The reciprocal pattern of diminished peripheral yet enriched pulmonary ILC3, together with a CXCL13-CXCR5 gradient, supports the selective recruitment of ILC3 from blood to lung parenchyma following Mycobacterium tuberculosis infection, sustaining type 3 inflammation beyond microbiological cure. Although the cross-sectional design and modest sample size limit causal inference, the findings align with experimental models and extend knowledge to human TOPD. Conclusion: TOPD is characterized by CXCL13-CXCR5–mediated trafficking of ILC3 that amplifies IL-23/IL-17/IL-22–driven airway inflammation, indicating this chemokine axis as a promising biomarker and therapeutic target for post-tuberculous airflow obstruction and progressive pulmonary decline.